Dimension Capital II, L.P.
SEC insider (Form 3/4/5 filer). CIK 0002040933. Director at Odyssey Therapeutics, Inc. (ODTX). 2 reported Form 4/5 transactions since Sep 2024; latest on May 8, 2026. Located in NEW YORK, NY.
Companies Dimension Capital II, L.P. has filed insider reports for
- Odyssey Therapeutics, Inc. (ODTX): Director
Dimension Capital II, L.P.
CIK: 0002040933
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ODTX
Odyssey Therapeutics, Inc.
Director